Dextroamphetamine Study Should Avoid Prior Stimulant Use, Pediatric Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA committee accepts recommendation from its Pediatric Ethics Subcommittee to allow a study of dextroamphetamine in healthy children to proceed. Stimulants should not be provided to participants prior to enrollment, committee says.